top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

1.750 +0.050 (+2.94%)
Streaming Delayed Price Updated: 12:13 PM EDT, May 28, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 232,573
Open 1.700
Bid (Size) 1.750 (1,500)
Ask (Size) 1.760 (11,500)
Prev. Close 1.700
Today's Range 1.690 - 1.760
52wk Range 1.330 - 2.260
Shares Outstanding 31,056,238
Dividend Yield N/A

Performance

YTD
-10.3%
-10.3%
1 Month
-7.4%
-7.4%
3 Month
-18.2%
-18.2%
6 Month
+13.6%
+13.6%
1 Year
-1.1%
-1.1%

More News

Read More

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 1.750
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 05/28/26 12:13 PM ET
What is the market capitalization of Inhibikase Therapeutics, Inc. - Common Stock?
The market capitalization of Inhibikase Therapeutics, Inc. - Common Stock is 54.35M
How many shares of Inhibikase Therapeutics, Inc. - Common Stock are outstanding?
Inhibikase Therapeutics, Inc. - Common Stock has 54M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
bottom of page